Table 1.
In vivo applications of cell encapsulation
| Polymer | Encapsulated cells | Application | References |
|---|---|---|---|
| Natural polymers | |||
| ALG microbeads | MSCs | MI | [58] |
| ALG-chitosan | (mESCs)-derived cardiomyocytes | MI | [59] |
| NPRLCs | ALF | [68] | |
| ALG-PEG | hMSCs | LF | [67] |
| Gelatin-ALG | hESC-RPE | MD | [15] |
| Synthetic polymers | |||
| PEGDA | NSCs and ECs | Stroke | [12] |
| PVA | hMSCs | Bone regeneration | [13] |
| Star-PEG-vinylsulfone | hiPSC-derived cardiomyocytes | MI | [19] |
| PEG | Dendritic cells | MS | [74] |
| TR-ZW | Islet cells | T1D | [40] |
ALG, alginate; MSCs, mesenchymal stem cells; MI, myocardial infarcation; ALF, acute liver failure; T1D, type 1 diabetes; ALG-chitosan, Alginate-chitosan; mESCs, mouse Embryonic Stem Cells; NPRLCs, Neonatal Porcine Reaggregated Liver cells; ALG-PEG, Alginate-Poly(ethylene glycol); hMSCs, human Mesenchymal Stem Cells; hESC-RPE, human Embryonic Stem Cell-derived Retinal Pigment Epithelial Cells; MD, macular degeneration; PEGDA, Polyethylene glycol diacrylate; NSCs, Neural stem cells; EC, Endothelial cells; PVA, Poly(vinyl alcohol); hiPSC, human-Induced Pluripotent Stem Cells; PEG, Poly(ethylene glycol); MS, Multiple Sclerosis; TR-ZW, Triazole-zwitterionic polymers